Marrow samples from 89 patients with aplastic anemia (AA) were evaluat
ed for their ability to grow stromal layers in standard long-term marr
ow cultures (LTMCs). Results were highly variable: 6.8% failed to grow
any stromal cells (group I); 42.5% either failed to grow to confluenc
y or appeared to have a decreased number of adipocytes and/or macropha
ges (group II); and 52.8% appeared as normal confluent cultures with f
ibroblasts, adipocytes, and macrophages (group III). Analyses of patie
nt data suggested that group I patients had a longer disease duration
and poorer survival (P = .07). Enzyme-linked immunosorbent assay analy
sis of cytokine production was performed on 20 of the normal-appearing
AA LTMCs and 12 LTMCs established from normal donors. Significant dif
ferences between the AA and control groups were apparent for macrophag
e inflammatory protein-1 alpha (MIP-1 alpha), interleukin-1 receptor a
ntagonist (IL-1ra), granulocyte-macrophage colony-stimulating factor (
GM-CSF), granulocyte colony-stimulating factor (G-CSF), and leukemia-i
nhibitory factor (LIF). The most dramatic differences observed were el
evated levels of MIP-1 alpha and GM-CSF and decreased levels of IL-1ra
, particularly after IL-1 alpha stimulation. In contrast. IL-1 alpha s
timulation of AA LTMCs produced levels of IL-6, LIF, and G-CSF compara
ble with those of controls. These data suggest that defects exist with
in the microenvironment of some AA marrows. Whether the majority of th
ese defects are the cause or consequence of aplasia is not clear. Howe
ver, we speculate that some of these abnormalities may contribute to t
he maintenance of the hypoplastic state and, in extreme cases, prevent
engraftment of donor marrow. (C) 1994 by The American Society of Hema
tology.